Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

9 Dec 2011 08:43

RNS Number : 6782T
CATCo Reinsurance Opps Fund Ltd
09 December 2011
 



THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL

 

CATCo Reinsurance Opportunities Fund Ltd.

 

("CATCo" or the "Company")

 

Net Asset Value(s) and Placing Price of new C-shares

 

Net Asset Value(s)

 

 

CATCo Investment Management Ltd, as Company Secretary, announces the unaudited net asset values of the Company's Ordinary Shares and C-shares of USD$1.0801 and USD$1.0314, respectively, as at the close of business on 30 November 2011.

 

On the 15 November 2011 the Board declared a final dividend of USD$0.051 for both the Ordinary and C-shares. The record date was 2 December 2011 and both the Ordinary and C-shares went ex-dividend on 30 November 2011.

 

Issue of new C-shares

 

Further to the announcement of 22 November, CATCo is pleased to announce the placing price of the new C shares to be issued under the Second Closing. A placing price of USD$1.0520 per C-share was calculated as the net asset value per C-share as at the close of business on 30 November 2011 plus 2 per cent (the "Placing Price"). The issue of new equity is a result of the placing commitments from institutional investors of USD$125 million which were announced to the market on 22 November 2011 (the "Placing").

 

The Placing Price for the new tranche of C-shares is calculated below taking into consideration the Company's dividend declaration:

 

C-share NAV as at 30 November 2011 (Ex-dividend)

USD$1.0314

Issue price for Placing C-share

USD$1.0520

Number of New C-shares to be issued

118,821,292

 

These 118,821,292 new C-shares form the Second Closing of a wider placing of up to 400 million New Shares to be admitted to trading on the Specialist Fund Market ("SFM"), which opened on 18 May 2011.

 

Timetable for the Second Closing

 

Admission of the second tranche of C-shares to trading on the London Stock Exchange's Specialist Fund Market

 

16 December 2011

CREST accounts to be credited in respect of the Depository Interests representing the second tranche of C-shares

 

16 December 2011

Admission of the second tranche of C-shares and the existing Ordinary Shares to trading on the Bermuda Stock Exchange

 

16 December 2011

 

Application has been made for these new C-shares to be admitted to trading on the London Stock Exchange's Specialist Fund Market. Trading is expected to commence on 16 December 2011. On Admission the Company will have in issue 87,642,000 Ordinary Shares and 244,118,029 C-shares.

 

Conversion of Second Closing C-shares into Ordinary Shares

 

In respect of the C-shares issued at both the First Closing and to be issued at the Second Closing, it is intended that such C-shares will convert into Ordinary Shares shortly after the date on which the Side Pocket Investment attributable to the New Zealand and the Japanese earthquakes is no longer designated as such and the relevant SP Shares held by the Company in respect of such exposures have converted back into Master Fund Shares.

 

Defined terms used in this Announcement shall have the same meaning as ascribed to them in the Company's Supplementary Prospectus dated 1 December 2011 and Prospectus dated 18 May 2011.

 

For further information contact:

 

CATCo Reinsurance Opportunities Fund Ltd

 

Jason Bibb (Chief Operating Officer)

Mark Way (Corporate Communications Director)

 

 

 

+1 (441) 531 2227

+44 (0) 7786 116 991

Numis Securities Limited

 

David Benda (Corporate Broking)

Hugh Jonathan (Corporate Finance)

Will Kostoris (Corporate Finance)

0207 260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEVKLBBFLFZFBL
Date   Source Headline
7th Jul 20062:51 pmRNSOffer for Cambridge Antibody
3rd Jul 20064:56 pmRNSDirectorate Change
30th Jun 20064:12 pmRNSHolding(s) in Company
30th Jun 20064:06 pmRNSDelisting
30th Jun 200610:27 amRNSAdditional Listing
30th Jun 20067:02 amRNSOffer for Cambridge Antibody
27th Jun 20062:26 pmRNSHolding(s) in Company
27th Jun 200612:34 pmRNSHolding(s) in Company
23rd Jun 20062:25 pmRNSAppointment of Directors
22nd Jun 20063:07 pmRNSRule 8.3- CAT
22nd Jun 200611:31 amRNSCAT Limited appoints new CE
22nd Jun 200611:11 amRNSEPT Disclosure
22nd Jun 200611:09 amRNSEPT Disclosure
22nd Jun 20067:02 amRNSOffer for Cambridge Antibody
21st Jun 20065:11 pmRNSRule 8.1- C.A.T.
21st Jun 200611:30 amRNSEPT Disclosure
21st Jun 200610:20 amRNSEPT Disclosure
20th Jun 200610:36 amRNSEPT Disclosure
20th Jun 200610:36 amRNSEPT Disclosure
19th Jun 20063:25 pmRNSRule 8.3 - Cambridge Antibody
19th Jun 20061:07 pmRNSRule 8.3- (CAT)
19th Jun 200611:30 amRNSEPT Disclosure
19th Jun 200611:23 amRNSEPT Disclosure
19th Jun 200610:33 amRNSEPT Disclosure
16th Jun 200611:45 amRNSEPT Disclosure
16th Jun 200611:24 amRNSEPT Disclosure
16th Jun 200611:08 amRNSEPT Disclosure
15th Jun 20065:01 pmRNSEPT Disclosure
15th Jun 20062:48 pmRNSRule 8.3- (CAT)
15th Jun 20062:17 pmRNSRule 2.10 Announcement
15th Jun 200612:45 pmRNSEPT Disclosure
15th Jun 200611:36 amRNSEPT Disclosure
14th Jun 20063:38 pmRNSRule 8.3- Cambridge Antibody
14th Jun 20063:05 pmRNSRule 8.3- Cambridge Antibody
14th Jun 20061:43 pmRNSRule 8.3- (CAT)
14th Jun 200611:36 amRNSEPT Disclosure
14th Jun 200611:15 amRNSEPT Disclosure
14th Jun 200610:59 amRNSEPT Disclosure
14th Jun 200610:23 amRNSEPT Disclosure
13th Jun 20064:50 pmRNSRule 8.3- Cambridge Antibody
13th Jun 20063:54 pmRNSRule 2.10 Announcement
13th Jun 200612:18 pmRNSEPT Disclosure
13th Jun 200611:42 amRNSEPT Disclosure
13th Jun 200611:35 amRNSEPT Disclosure
13th Jun 200610:20 amRNSEPT Disclosure
12th Jun 20065:35 pmRNSRule 8.3 - Cambridge Antibody
12th Jun 200612:00 pmRNSEPT Disclosure
12th Jun 200611:34 amRNSEPT Disclosure
12th Jun 200611:14 amRNSRule 8.3- (CAT)
12th Jun 200610:08 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.